ArticleScience (New York, N.Y.)2016

Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.

Christoph T Ellebrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.